Striders Impex IPO Day 1: Subscription at 0.00x, GMP Flat | Live Updates

Posted by : Ekta Dhawan | Thu Feb 26 2026

The Striders Impex IPO GMP is ₹0 as of 26th February 2026. It is a book-building issue IPO of ₹36.29 crores. This is an entirely fresh issue of 0.45 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 6th March 2026. The face value of Striders Impex IPO shares is ₹10 per share, and the IPO price band is ₹71 to ₹72 per share. Retail investors can bid for a minimum of 2 lots of 3,200 shares worth ₹2,30,400. Scroll down to check the Striders Impex IPO GMP and subscription details.

Table of Contents

Striders Impex IPO GMP Grey Market Premium

As mentioned earlier, the Striders Impex IPO GMP currently stands at ₹1.50 per share. Thus, the estimated listing price would be at ₹387.00. This indicates that the estimated listing gain in this IPO could be 0.39%. Explore the table for Striders Impex IPO GMP updates.

GMP DATE	IPO Price	GMP Price	Estimated Listing Price	Estimated Gain
26-2-2026	₹72.00	0.00	72.00	0.00%
25-2-2026	₹72.00	0.00	72.00	0.00%
24-2-2026	₹72.00	0.00	72.00	0.00%
23-2-2026	₹72.00	0.00	72.00	0.00%
22-2-2026	₹72.00	0.00	72.00	0.00%
21-2-2026	₹72.00	0.00	72.00	0.00%
20-2-2026	₹72.00	0.00	72.00	0.00%

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Striders Impex IPO GMP status at Univest.

Click and Sign Up to Get Live Updates on Striders Impex IPO GMP Status

Striders Impex IPO Subscription Status

As of now, the Striders Impex IPO has been subscribed to 0.00 times. Of these, 0.00 times are subscribed by retail investors, 0.00 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).

The healthy subscription status indicates that investors are expecting higher returns at the time of Striders Impex’s IPO listing on 5th March 2026. Striders Impex also has a positive outlook behind the fresh issue of 0.55 crore shares, which will raise around Rs 80.11 crores.

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Striders Impex IPO Subscription status at Univest.

Click and Sign Up to Get Live Updates on Striders Impex IPO Subscription Status

Striders Impex IPO Details

IPO Allotment Date	4th March 2026
IPO Open Date	26th February 2026
IPO Close Date	2nd March 2026
Refund Initiation	5th March 2026
Issue Size	50,40,000 shares(agg. up to ₹36 Cr)
Fresh Issue	42,78,400 shares(agg. up to ₹31 Cr)
Offer for Sale	5,08,800 shares of ₹10(agg. up to ₹4 Cr)
Face Value	₹10 per share
Lot Size	1,600 Shares
Issue Price	₹71 to ₹72 per share
Issue Type	Bookbuilding IPO
Listing At	NSE & SME
Listing Date	6th March 2026

Also Read: Striders Impex IPO GMP & Review: Apply or Avoid?

Explanation

Striders Impex IPO: Striders Impex IPO Limited has declared an issue price band of ₹71 to ₹72 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 3,200 shares, each worth ₹2,30,400. The face value of Striders Impex IPO Limited shares is ₹10 per share. The shares of Striders Impex IPO Limited will be listed on NSE and SME on its tentative listing day, 6th March 2026. Scroll down to check GMP updates and Striders Impex IPO reviews.

About Striders Impex Ltd.

Striders Impex Limited was founded in 2021 and is involved in licensing and own-brand development. The company delivers various solutions, from product design and development to sourcing, producing, and distributing in Indian and international markets. The company’s focus is to expand its market presence by reaching cities through effective retail distribution.

Asset-Light Business Model
Trusted Licensing Partnerships with Global Brands
Brand Equity and Consumer Liking
Strategic Presence in High-Growth Markets
Strategic Presence in High-Growth Markets
Diversified Revenue Base Across Channels and Geographies

Striders Impex Limited Financials

The company’s financial analysis is essential before applying for the Striders Impex IPO. See the table for Striders Impex Limited’s financials.

Year Ended	30th Sp 2025 (in cr.)	31st March 2025 (in cr.)	31st March 2024 (in cr.)
Assets	58.83	48.70	20.45
Total Income	49.61	61.95	41.77
Profit After Tax	49.61	8.41	4.39
EBITDA	6.49	9.32	5.32
Net Worth	23.53	14.88	6.47
Reserves and Surplus	10.04	15.06	6.46
Total Borrowings	22.92	20.55	14.65

Explanation

Striders Impex Limited’s revenue increased by 92.20% from ₹181.95 crores in March 2024 to ₹349.71 crores in March 2025. Moreover, the company’s PAT increased by 131.99% from ₹18.91 crores in March 2024 to ₹43.87 crores in March 2025.

Striders Impex IPO Objectives

The primary aim of the Striders Impex IPO is to raise ₹36.29 crores. On the other hand, Fractal Analytics has decided to utilise these funds in different ways.

Funding of the working capital requirements of the Company
Investment in Striders FZ LLC, a wholly owned subsidiary, to fund its working capital requirements;
Investment in Striders FZ LLC, a wholly owned subsidiary, to fund its working capital requirements.
Repayment of Loans
To meet the corporate requirements

Striders Impex IPO Registrar

MUFG Intime India Private Limited is the registrar for the Striders Impex IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Striders Impex allotment and refund, you can contact MUFG Intime India Private Limited at omnitechengineering.ipo@in.mpms or at +91-22-4918 6270.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Striders Impex IPO Review

The Striders Impex IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Ans. Striders Impex Limited’s revenue increased by 92.20% from ₹181.95 crores in March 2024 to ₹349.71 crores in March 2025. Moreover, the company’s PAT increased by 131.99% from ₹18.91 crores in March 2024 to ₹43.87 crores in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Striders Impex IPO or not.

Key Indicators	Value
PE Ratio (Price-to-Earnings)	12.06
EPS (Earnings Per Share)	5.97
RoNW	17.05%
ROCE	25.98%
ROE	–
EBITDA Margin	13.09%
Price to Book Value	4.22
Market Capitalisation	₹134.04

The P/E ratio of Striders Impex Limited shares is 12.06, and its Earnings Per Share (EPS) stands at 5.97. Thus, the Striders Impex IPO can deliver gains on its tentative listing date, 5th March 2026.

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Striders Impex Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.

Indicators	Pre-IPO	Post-IPO
PE Ratio	12.06	25.07
EPS	5.97	2.87

FAQs on Striders Impex IPO

What is the Striders Impex IPO GMP?

Currently, on 26th February 2026, the Striders Impex IPO GMP (Grey Market Premium) stands at ₹0.00. This indicates that the estimated listing price could be ₹72 per share.

What is the issue Size of the Striders Impex IPO?

Ans. Striders Impex IPO is a bookbuilding IPO of ₹36.29 crores. Moreover, the IPO is set to open on 26th February 2026 and close on 2nd March 2026.

Who is the registrar of the Striders Impex IPO?

Ans. MUFG Intime India Private Limited is the registrar for the Striders Impex IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Striders Impex allotment and refund, you can contact MUFG Intime India Private Limited at yaapdigital.smeipo@in.mpms.mufg.com or at +91-22-4918 6270.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Striders Impex IPO, download the Striders Impex IPO RHP and Striders Impex IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.